A concentration of 1 μg/mL of CD80+VEGF protein-conjugated nanoparticles given in multiple treatments was the optimal system and dosing frequency at arresting OSA cell proliferation. This evidence concerns the gene CD80 and obstructive sleep apnea syndrome.